Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Julie, Settles"'
Autor:
Julie Settles, Deborah Hinnen, Erik Spaepen, Sanjay Bajpai, Ankit Turakhiya, Shirin Ghodke, Christopher J. Child
Publikováno v:
Endocrine Practice. 28:486-493
To evaluate ease of use, user preference, and effort required to use nasal glucagon (NG) versus injectable glucagon needing reconstitution (IG) in simulations of severe hypoglycemia (SH)-a challenge for caregivers of a person with diabetes (PWD) in r
Autor:
Julie Settles, Hong Kan, Christopher J. Child, Magdaliz Gorritz, Jasjit K. Multani, Catherine B. McGuiness, Rolin L. Wade, Brian M. Frier
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1235-1244
Several risk factors for severe hypoglycaemia (SH) are associated with insulin-treated diabetes. This study explored potential risk factors in adults with insulin-treated type 2 diabetes mellitus (T2DM).In this case-control study, adults with T2DM in
Autor:
Julie Settles, Christopher J. Child, Magdaliz Gorritz, Jasjit K. Multani, Catherine B. McGuiness, Rolin L. Wade, Hong Kan, Alexander Stöckl
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
null Julie Settles, null Hong Kan, null Christopher J. Child, null Magdaliz Gorritz, null Jasjit K. Multani, null Catherine B. McGuiness, null Rolin L. Wade, null Brian M. Frier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525b9cef09888dd4d2d53456bd794e75
https://doi.org/10.1111/dom.14690/v3/response1
https://doi.org/10.1111/dom.14690/v3/response1
Autor:
Hong Kan, Magdaliz Gorritz, Jasjit K. Multani, Rolin L Wade, Christopher J. Child, Catherine B McGuiness, Julie Settles
Publikováno v:
Diabetes. 70
Background: In insulin-treated patients (pts) with T2DM, untreated severe hypoglycemia (SH) can be life-threatening. We used a healthcare claims database (db) to identify less established SH risk factors in this group. Methods: Adults with T2DM and
Autor:
Julie Settles, Christopher J. Child, Jeffrey G. Suico, E Moennig, Gregg Gerety, Erik Spaepen, B Sanjay
Publikováno v:
Präzisionsmedizin – Eine Reise in die Zukunft der Diabetologie www.diabeteskongress.de.
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 26(4)
Objective: A severe hypoglycemia (SH) episode is an acute, high-stress moment for the caregivers of persons with diabetes (PWD). We compared the success rates of nasal glucagon (NG) and injectable glucagon (IG) administration for PWD-trained and untr
13-LB: Nasal vs. Injected Glucagon: User Experience Results of a Simulated Severe Hypoglycemia Study
Publikováno v:
Diabetes. 68
Injectable glucagon (IG) is challenging to use for caregivers of a person with diabetes (PWD) in stressful severe hypoglycemia (SH) rescue. We evaluated user preference for nasal glucagon (NG) and IG devices after treating simulated SH. The PWD train
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 22(2)
To describe glucagon prescription patterns in patients with type 1 (T1DM) or type 2 diabetes (T2DM) who received an initial insulin prescription.Retrospective analyses were conducted with data from Truven Health MarketScan databases to assess time to
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 21(7)
To compare the efficacy and safety of 2 dosing regimens for human regular U-500 insulin (U-500R, 500 units/mL) replacing high-dose U-100 insulins with or without oral antihyperglycemic drugs in patients with inadequately controlled type 2 diabetes (T